The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

19 Jun 2009 10:53

RNS Number : 1852U
Aortech International PLC
19 June 2009
 



TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES

 

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

AorTech International plc

2. Reason for the notification (please state Yes/No): ( )

An acquisition or disposal of voting rights: ( Yes )

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( )

An event changing the breakdown of voting rights: ( )

Other (please specify)( Yes )

Exemption Trading Book DTR 5.1.3(4)

3. Full name of person(s) subject to the notification obligation (iii):

The Goldman Sachs Group, Inc.

4. Full name of shareholder(s) (if different from 3.) (iv):

Goldman Sachs Bank AG

Goldman Sachs International

 

5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v):

  11 June 2009

6. Date on which issuer notified:

15 June 2009

7. Threshold(s) that is/are crossed or reached:

Below 3%

 

8. Notified details:

A: Voting rights attached to shares

Class/type of shares if possible using the ISIN CODE

Situation previous to the Triggering transaction (vi)

Number of shares

Number of voting Rights (viii)

GB0033360586

328,594

6.80%

Resulting situation after the triggering transaction (vii)

Class/type of shares if possible using the ISIN CODE

Number of shares

Number of voting rights (ix)

% of voting rights

Direct (x)

Indirect (xi)

Direct

Indirect

GB0033360586

B: Financial Instruments

Resulting situation after the triggering transaction (xii)

Type of financial instrument

Expiration Date (xiii)

Exercise/Conversion Period/Date (xiv)

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

N/A

N/A

N/A

N/A

N/A

Total (A+B)

Number of voting rights

% of voting rights

Below 3%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv):

As at close of business on 11 June 2009, The Goldman Sachs Group, Inc., of 85 Broad StreetNew YorkNY 10004USA, no longer has a notifiable interest in shares.

Proxy Voting:

 

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

General email contact:

shareholderdisclosures@gs.com

14. Contact name:

Shannon Sutherland 

15. Contact number:

0207 774 6249

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGUUUAQUPBUBB
Date   Source Headline
17th Jun 20207:00 amRNSChange of Name and Rebranding
8th Jun 20207:00 amRNSUpdate on Elective Surgery and Customer Orders
27th May 20207:00 amRNSNew Patent
20th May 20207:00 amRNSGrant Funding for Subsidiary
13th May 20207:00 amRNSTrading Update
14th Apr 202010:27 amRNSFurther Update re COVID-19
2nd Apr 20202:13 pmRNSHolding(s) in Company
1st Apr 20201:36 pmRNSDirector/PDMR Shareholding
31st Mar 202010:28 amRNSResult of General Meeting and Total Voting Rights
30th Mar 20203:37 pmRNSUpdate re Acquisition of RUA and COVID-19
25th Mar 20207:00 amRNSUpdate re Acquisition and General Meeting
11th Mar 20207:00 amRNSProposed Acquisition of RUA Medical & Name Change
21st Jan 20207:00 amRNSExtension to Agreement with RUA Medical
6th Jan 20207:00 amRNSHeart Valve Development Update
2nd Dec 20197:00 amRNSNew Share Option Scheme and Grant of Share Options
29th Nov 20197:00 amRNSHalf-year Report
27th Nov 20191:09 pmRNSNew Licence Agreement
11th Oct 20197:00 amRNSTrading Update
3rd Sep 20191:14 pmRNSHolding(s) in Company
19th Aug 20192:53 pmRNSResult of AGM
5th Aug 20191:36 pmRNSPosting of Report & Accounts and Notice of Meeting
29th Jul 201912:52 pmRNSHolding(s) in Company
17th Jul 20197:00 amRNSFinal Results
8th Jul 201911:05 amRNSSecond Price Monitoring Extn
8th Jul 201911:00 amRNSPrice Monitoring Extension
19th Jun 20197:01 amRNSChange of Adviser
19th Jun 20197:00 amRNSDirectors' Disclosures
17th Jun 201910:47 amRNSDirectors' Disclosures
14th May 20197:00 amRNSTrading Update
24th Jan 201912:36 pmRNSCompany Update
22nd Nov 20187:00 amRNSInterim Results
15th Oct 20185:34 pmRNSHolding(s) in Company
5th Sep 20187:00 amRNSHolding(s) in Company
30th Aug 201811:18 amRNSHolding(s) in Company
23rd Aug 20182:03 pmRNSResult of AGM
23rd Aug 20187:00 amRNSAGM Statement
26th Jul 20183:33 pmRNSHolding(s) in Company
25th Jul 20184:40 pmRNSSecond Price Monitoring Extn
25th Jul 20184:35 pmRNSPrice Monitoring Extension
20th Jul 20187:00 amRNSFinal Results
4th Jul 20187:00 amRNSNew Patent Issued
28th Jun 20187:00 amRNSDevelopment and Supply Agreement with RUA Medical
26th Jun 201812:49 pmRNSNew Patent Issued
19th Jun 20189:30 amRNSDevelopment Agreement Signed
15th Jun 20183:54 pmRNSHolding(s) in Company
13th Jun 201811:47 amRNSHolding(s) in Company
8th Jun 201812:02 pmRNSResult of GM and TVR
8th Jun 20187:00 amRNSResult of Open Offer
22nd May 201812:00 pmRNSPosting of Circular
21st May 20187:00 amRNSConditional Placing and Proposed Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.